Autoimmunity Clinical Trials
2 recruiting trials for Autoimmunity. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Autoimmunity clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Scientific Institute San Raffaele (1), Göteborg University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation (other, 1 trial), followed by gluten-free, probiotic.
Track Autoimmunity trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic...
Myocarditis is a complex inflammatory disease, usually occurring secondary to viral infections, autoimmune processes or toxic agents. Clinical presentations are multiple,...
Gfree - For Improved Blood Sugar and Reduced Inflammation.
The goal of this clinical trial is to reduce inflammation and improve glycemic control in healthy volunteers, parents, as well as children, adolescents and adults with or without...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Autoimmunity, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Autoimmunity, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Autoimmunity, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.